Maintenance of platelet inhibition during antiplatelet therapy
US9320754B2 · kind B2 · utility
4Cited by
12References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2014 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | May 5, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.